Literature DB >> 6381060

Correlation between serum antibody-levels against group B streptococci and gestational age in newborns.

K K Christensen, P Christensen, G Duc, P Höger, C Kind, T Matsunaga, B Müller, R A Seger.   

Abstract

Sera from 33 newborn infants with gestational ages ranging from 27 to 41 weeks were tested by radioimmunoassay for IgG antibodies to surface antigens of group B streptococci (GBS) types Ia, Ib, II and III. Antibody levels to GBS antigens were positively correlated to gestational age and birthweight. However, only the correlations for anti-Ia and anti-II antibody levels reached statistical significance. Mean antibody concentrations in infants below 34 weeks of gestation were significantly lower for type Ia (P less than 0.001), type II (P less than 0.001) and type III (P = 0.05) than in infants above this limit. These findings might explain the higher rate of serious GBS-infections found among prematures as compared to full-term infants.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6381060     DOI： 10.1007/bf00445584

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  18 in total

1.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

2.  Serum gamma-G-globulin levels and gestational age in premature babies.

Authors:  J R Hobbs; J A Davis
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

Review 3.  Group B streptococcal infections.

Authors:  C J Baker
Journal:  Adv Intern Med       Date:  1980

4.  Differences in anti-protein A activity among IgG subgroups.

Authors:  G Kronvall; R C Williams
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

5.  Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport.

Authors:  P F Kohler; R S Farr
Journal:  Nature       Date:  1966-06-04       Impact factor: 49.962

6.  IgG subclasses: development of the serum concentrations in "normal" infants and children.

Authors:  A Morell; F Skvaril; W H Hitzig; S Barandun
Journal:  J Pediatr       Date:  1972-06       Impact factor: 4.406

7.  Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates.

Authors:  A O Shigeoka; J I Santos; H R Hill
Journal:  J Pediatr       Date:  1979-09       Impact factor: 4.406

8.  Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.

Authors:  V G Hemming; R T Hall; P G Rhodes; A O Shigeoka; H R Hill
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus.

Authors:  C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

10.  Quantitation of serum antibodies to surface antigens of group B streptococci types Ia, Ib, and III: low antibody levels in mothers of neonatally infected infants.

Authors:  K K Christensen; P Christensen; K Dahlander; G Faxelius; B Jacobson; N Svenningsen
Journal:  Scand J Infect Dis       Date:  1980
View more
  3 in total

1.  Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.

Authors:  T Lagergård; K Thiringer; L Wassén; R Schneerson; B Trollfors
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

2.  Intravenous administration of human IgG to newborn infants: changes in serum antibody levels to group B streptococci.

Authors:  K K Christensen; P Christensen; H U Bucher; G Duc; C H Kind; D Mieth; B Müller; R A Seger
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183

Review 3.  Vaccination of HIV-infected pregnant women: implications for protection of their young infants.

Authors:  Ziyaad Dangor; Marta C Nunes; Gaurav Kwatra; Sanjay G Lala; Shabir A Madhi
Journal:  Trop Dis Travel Med Vaccines       Date:  2017-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.